Amanta Healthcare Schedules Analysts and Institutional Investors Meeting for April 2026

Amanta healthcare Limited has announced a scheduled meeting with analysts and institutional investors, providing transparency and engagement opportunities for the investment community. The company has formally notified stock exchanges about this upcoming interaction as part of its regulatory compliance obligations.

Meeting Details and Schedule

The company has scheduled a comprehensive meeting with analysts and institutional investors for April 7, 2026. The meeting will take place at Kheda, Gujarat, and will feature both group discussions and a site visit to provide participants with firsthand insights into the company's operations.

Parameter:	Details
Date:	Tuesday, April 7, 2026
Venue:	Kheda, Gujarat
Format:	Group Meeting - In person
Activities:	Site Visit

Regulatory Compliance and Transparency

The meeting notification has been made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory framework ensures that all stakeholders are informed about significant corporate interactions and maintains market transparency.

The company has specifically noted that no unpublished price sensitive information pertaining to the company will be shared during the meeting with analysts and institutional investors. This commitment ensures compliance with insider trading regulations and maintains fair market practices.

Flexibility and Adaptability

Amanta Healthcare has indicated that the scheduled meeting may undergo changes due to exigencies on the part of the analysts, investors, or the company. This flexibility allows for accommodation of unforeseen circumstances while maintaining the commitment to stakeholder engagement.

The notification was signed by Nikhita Dinodia, Company Secretary and Compliance Officer, demonstrating proper corporate governance and authorized communication channels. The company maintains its registered and corporate office at Shaligram Corporates, CJ Marg, Ambli, Ahmedabad, Gujarat.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+2.14%	+9.59%	+4.97%	-20.73%	-23.76%	-23.76%

Amanta healthcare Limited has filed its annual regulatory disclosures under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ended March 31, 2026. The company submitted the mandatory compliance documents to both stock exchanges on April 2, 2026.

Regulatory Filing Details

The disclosures were filed under Regulation 31(4) of SEBI SAST Regulations with both BSE Limited and National Stock Exchange of India Limited. The company maintains its listing on both exchanges with specific identifiers for trading purposes.

Exchange Details:	Information
BSE Scrip Code:	544502
NSE Trading Symbol:	AMANTA
Filing Date:	April 2, 2026
Financial Year:	2025-26

Promoter Group Declaration

Chairman & Managing Director Bhavesh G. Patel, representing the promoter and promoter group, has made a comprehensive declaration regarding share encumbrance. The promoter group has confirmed that no encumbrance was created, directly or indirectly, on the shares or securities of Amanta Healthcare Limited during the financial year 2025-26.

This declaration ensures transparency in promoter holdings and compliance with SEBI's substantial acquisition and takeover regulations. The filing demonstrates the company's commitment to maintaining proper corporate governance standards and regulatory adherence.

Corporate Compliance

The annual disclosures were executed by key company officials to ensure proper authorization and compliance. Company Secretary & Compliance Officer Nikhita Dinodia coordinated the filing process, while promoter Bhavesh Girishbhai Patel provided the necessary declarations on behalf of the promoter group.

Signatory Details:	Role
Nikhita Dinodia:	Company Secretary & Compliance Officer
Bhavesh G. Patel:	Promoter, Chairman & Managing Director
Document Type:	Annual SEBI SAST Disclosure
Regulation:	31(4) of SEBI SAST Regulations, 2011

The company operates from its registered and corporate office located at 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad-380058, Gujarat. These annual disclosures form part of the company's ongoing regulatory obligations as a listed entity, ensuring transparency in promoter activities and shareholding patterns for investor protection and market integrity.